The Food and Drug Administration announced stricter limits on conflicts of interests for members of its advisory committees.
The Food and Drug Administration this week announced stricter limits on conflicts of interests for members of its advisory committees. The federal agency also adopted improved voting procedures and an improved process for disclosing information about advisory members and matters considered at their meetings. All of the changes will be implemented within 120 days. "The FDA's regulatory decisions affect the health of millions of Americans, and we don't make those decisions in a vacuum," Randall Lutter, the FDA's deputy commissioner for policy said. "It's imperative that we seek advice from independent experts, and that we do so in a way that is public, open, and transparent."